Navigation Links
Correction: Shire plc: Third Quarter 2007 results date notification November 1, 2007
Date:10/17/2007

BASINGSTOKE, England, Oct. 17 /PRNewswire-FirstCall/ -- Below is updated text of Shire plc's conference call notification. Please note U.S. release times and conference call times have been updated from an earlier release.

Shire PLC (LSE: SHP, Nasdaq: SHPGY, TSX: SHQ) the global specialty biopharmaceutical company, will announce third quarter 2007 earnings on Thursday 1 November 2007.

Results press release will be issued at: 12:00 GMT / 08:00 ET

Investor meeting and conference call time: 14:30 GMT / 10:30 ET

Live conference call for investors:

Matthew Emmens, Chief Executive Officer and Angus Russell, Chief Financial Officer will host the live conference call for investors at 14:30 GMT/10:30 ET.

Please RSVP ssalah@shire.com (T: +44(0)1256-894-160) for this conference call.

The details of the conference call are as follows:

UK dial in: +44(0)800-953-0810,

US dial in: +1-866-789-2220,

International dial in: +44(0)1452-560-068,

Password/Conf ID: 20443623#

Live Webcast:*

http://www.shire.com/shire/InvestorRelations/events.jsp?tn=2&m1=33

Replay:

A replay of the presentation will be available for two weeks by phone and by webcast for one year. Details are as follows:

UK dial in: +44(0)800-953-1533,

US dial in: +1-866-247-4222,

International dial in: +44(0)1452-55-00-00,

Pin code: 20443623#

Webcast replay:*

http://www.shire.com/shire/InvestorRelations/events.jsp?tn=2&m1=33

* Email verification is required

Notes to editors

Shire PLC

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe. Shire believes that a carefully selected portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company's website: http://www.shire.com.


'/>"/>
SOURCE Shire PLC
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Visions: Broderick says Wisconsin should be in top third in venture capital
2. Third Wave files countersuit vs. Digene in patent case
3. Third Wave reports net loss of $18.9M for 2006
4. Stratagene to pay Third Wave $10.75M in patent case
5. Third Wave responds to Digene patent lawsuit
6. Third Wave seeks approval of Cystic Fibrosis test
7. Third Wave Technologies to raise $14.9M through private debt
8. Venture capital above $6B for third straight quarter
9. Third Wave reports $5.2M third quarter loss
10. Third Wave reports another loss, stronger sales
11. Napier joins board of Third Wave Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... Cancer ... exhibiting in booth 513 at the Association of Community Cancer Centers (ACCC) 43rd ... 29-31. , CANCERSCAPE unites key stakeholders from leading national organizations to share ...
(Date:3/29/2017)... COLUMBIA, MO , March 29, 2017 /PRNewswire/ - ... and its partners Nordion, a business of Sterigenics International, ... Request (LAR) has been submitted to the U.S. Nuclear ... implementing domestic U.S. production of molybdenum-99 (Mo-99). Once operational, ... nearly half of U.S. demand for Mo-99, which currently ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... Association for the Advancement of Science (AAAS), the world's largest general scientific ... enhance its high-impact scholarly collection across its cross-platform reference management system. , ...
(Date:3/28/2017)... Philadelphia, PA (PRWEB) , ... March 28, 2017 ... ... Johnston, spoke at a Marketing Roundtable on March 22 in Philadelphia. The event ... WHYY. , The Marketing Roundtable featured breakout groups and interaction ...
Breaking Biology Technology:
(Date:2/28/2017)... 2017   Acuant , a leading provider of ... enhancements to new and core technologies building upon the ... mobile and desktop Acuant FRM TM facial recognition ... real time manual review of identity documents by accredited ... fastest and most accurate capture software to streamline workflows ...
(Date:2/26/2017)... , Feb. 25, 2017  Securus Technologies, ... technology solutions for public safety, investigation, corrections and ... Recidivism and Reentry. "Too often, too ... prisons and county jails are trying to tackle ... inmates and friends and family members. While significant steps ...
(Date:2/21/2017)... Der weltweite Biobanking-Sektor wird bis ... Gespräch mit mehr als 50 Vertretern aus verschiedenen Branchen wurde ... um diese Prognose zu realisieren. ... Zu den Schwierigkeiten ... Mittel für die Biobank, die Implementierung Zeit sparender Technologien, ...
Breaking Biology News(10 mins):